StockData
Organon & Co. logo

Organon & Co. (OGN) income statement

OGNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 7/3013% above fair value
$13.92+0.02 (+0.14%)

Close on Nov 18, 2026Market cap $3.66BP/E 18.1Yield 2.44%

Organon & Co. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
53.1%
Operating margin
–
Net margin
3.5%
Return on equity, FY2025
30.6%

Financial strength

Current ratio
2.02
Debt to equity
7.17
Debt to assets
63.8%
Cash to current liabilities
54.9%

Valuation

P/E ratio
18.1
Price to sales
0.60
Price to book
3.06
Dividend yield
2.44%

See a number that looks wrong?